FTRE vs. RDNT, GH, VCYT, EXAS, NTRA, SWTX, IOVA, TXG, SHC, and HCM
Should you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include RadNet (RDNT), Guardant Health (GH), Veracyte (VCYT), Exact Sciences (EXAS), Natera (NTRA), SpringWorks Therapeutics (SWTX), Iovance Biotherapeutics (IOVA), 10x Genomics (TXG), Sotera Health (SHC), and HUTCHMED (HCM). These companies are all part of the "medical" sector.
Fortrea (NASDAQ:FTRE) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.
RadNet has a net margin of 0.19% compared to Fortrea's net margin of 0.00%. RadNet's return on equity of 4.72% beat Fortrea's return on equity.
In the previous week, Fortrea had 3 more articles in the media than RadNet. MarketBeat recorded 7 mentions for Fortrea and 4 mentions for RadNet. Fortrea's average media sentiment score of 0.98 beat RadNet's score of 0.64 indicating that Fortrea is being referred to more favorably in the media.
Fortrea presently has a consensus target price of $37.29, indicating a potential upside of 1.29%. RadNet has a consensus target price of $53.67, indicating a potential upside of 6.38%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Fortrea.
RadNet received 334 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 65.83% of users gave RadNet an outperform vote while only 38.46% of users gave Fortrea an outperform vote.
RadNet has lower revenue, but higher earnings than Fortrea.
77.9% of RadNet shares are owned by institutional investors. 0.1% of Fortrea shares are owned by insiders. Comparatively, 4.4% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
RadNet beats Fortrea on 11 of the 15 factors compared between the two stocks.
Get Fortrea News Delivered to You Automatically
Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
